Estrella Immunopharma, Inc. (ESLA) Accounts Receivable, after Allowance for Credit Loss, Current USD 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Estrella Immunopharma, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate for 2023.
Estrella Immunopharma, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2023 was $273 K.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$273 K			Jun 30, 2023	10-Q	2023-11-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.